 BEVACIZUMAB AND TRASTUZUMAB WITH WEEKLY PACLITAXEL FOLLOWED, AFTER SURGERY, BY ENCAPSULED LIPOSOMAL DOXORUBICIN, CYCLOPHOSPHAMIDE AND TRASTUZUMAB AS ADJUVANT TREATMENT AFTER SURGERY ON WOMEN WITH HER2 BREAST CANCER: 